Aporphines. 9. Synthesis and Pharmacological Evaluation of (±) 9, 10-Dihydroxyaporphine [(±)-Isoapomorphine], (±)-,(-)-, and (±)-1,2-Dihydroxyaporphine, and (+)-1, 2, 9, 10 - Tetrahydroxyaporphine.
Aporphines. 9. Synthesis and Pharmacological Evaluation of (±) 9, 10-Dihydroxyaporphine [(±)-Isoapomorphine], (±)-,(-)-, and (±)-1,2-Dihydroxyaporphine, and (+)-1, 2, 9, 10 - Tetrahydroxyaporphine.
复制标题
9. (±) 9, 10-二羟基阿朴啡[(±)-异扑吗啡]、(±)-、(-)-、(±)-1,2-二羟基阿朴啡和(+)的合成和药理学评价-1,2,9,10-四羟基阿朴啡。
DOI:
10.1021/jm00269a602
复制
发表时间:
1973
影响因子:
7.3
通讯作者:
D. Teiger
中科院分区:
文献类型:
--
作者:
J. Neumeyer;M. McCarthy;S. Battista;F. Rosenberg;D. Teiger
The synthesis and preliminary pharmacological evaluation of the title compounds2-4 are described and compared with those of (-)-nuciferine and (-)-apomorphine [(-)-!]. The method used for the synthesis of (±)-2 involved modifications of the Reissert alkylation-Pschorr cyclization route previously employed for the synthesis of apomorphine and apocodeine. Two alternative sequences of reactions (9a— 10a—13a 13b—* 13c or 9a—* 9b—10b—13c) were investigated for the preparation of the Pschorr precursor 13c. O-Demethylation of (±)-6, nuciferine, and glaucine was accomplished with 57% HI in Ac20 to givethe desired hydroxyaporphines 2-4. The pharmacological results indicatedthat emetic and CNS activity resides principally in those aporphines that are substituted with phenolic hydroxyl groups in the 10 and 11 positions. Shifting the hydroxyl groups to positions 9, 10 or to positions 1.2 markedly reduced pharmacological potency. Similarly, the tetrahydroxyaporphine substituted in the 1, 2, 9, 10 positions also markedly reduced the activity in comparison with apomorphine.In our previous study1 we described the successful total synthesis of five racemic aporphines functionally substituted on the nitrogen atom and on the 10 and 11 posi-tions. The procedure was applicable to the synthesis of aporphines not derivable from the naturally occurring opium alkaloids (ie, morphine and codeine). Preliminary pharmacological evaluation of (-)-apomorphine and (±)-apomorphine and their corresponding JV-propyl homologs